Author
@nextbigtrade nextbigtrade
grade Bx.com/nextbigtrade ↗
Stage-analysis momentum trader tracking leading-sector rotation and blow-off top risk
Runs a paid trading newsletter; posts real-time chart-based
trader score
-1.29
hit rate
35%
mean α
-1.02%
signals 14d
100
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 35% hit rate, -1.02% mean alpha, trader score -1.29. Their last-14d mentions, direction-adjusted, have moved +1.5% since posting (mean over 63 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-10-16 | MRNA | @nextbigtrade | -0.20 | Reports a Goldman target increase to $137 with mocking laughter. | -8.2% | tweet ↗ |
| 2026-10-16 | BND | @nextbigtrade | +0.45 | Notes two consecutive weeks of strong upside volume near the low. | +0.5% | tweet ↗ |
| 2026-10-16 | SPX | @nextbigtrade | +0.15 | Observes positive broad breadth despite sharp technology weakness. | · | tweet ↗ |
| 2026-10-16 | XLF | @nextbigtrade | +0.45 | Reports that XLF reversed an initial weekly decline to the upside. | +0.7% | tweet ↗ |
| 2026-10-16 | MRNA | @nextbigtrade | +0.90 | Says MRNA could become a ten-bagger this year. | -8.2% | tweet ↗ |
| 2026-10-16 | MRNA | @nextbigtrade | +0.50 | Describes a hostile, narrow market where MRNA and semiconductor shorts worked. | -8.2% | tweet ↗ |
| 2026-10-16 | MRNA | @nextbigtrade | +0.50 | MRNA remains above short-term moving averages despite market weakness. | -8.2% | tweet ↗ |
| 2026-10-16 | MRNA | @nextbigtrade | +0.70 | Recaps a newsletter buy now up more than 70%. | -8.2% | tweet ↗ |
| 2026-10-16 | MRNA | @nextbigtrade | +0.70 | Claims Stage Analysis traders are already profiting in MRNA. | -8.2% | tweet ↗ |
| 2026-10-15 | SNDK | @nextbigtrade | +0.00 | Says MRNA surpassed SNDK as 2026's top-performing stock. | -11.2% | tweet ↗ |
| 2026-10-15 | MRNA | @nextbigtrade | +0.65 | Says MRNA surpassed SNDK as 2026's top-performing stock. | -15.4% | tweet ↗ |
| 2026-10-15 | · | @nextbigtrade | · | Uses 1991-1995 as an analog for prolonged chop followed by a strong trend. | · | tweet ↗ |
| 2026-10-15 | TLT | @nextbigtrade | +0.55 | TLT gaps higher on unusually large volume. | +1.7% | tweet ↗ |
| 2026-10-15 | MRNA | @nextbigtrade | +0.75 | Expresses a clear view that MRNA wants to move much higher. | -15.4% | tweet ↗ |
| 2026-10-15 | NDX | @nextbigtrade | -0.50 | Reports heavy daily downside volume in NDX. | · | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.